178 related articles for article (PubMed ID: 32323899)
1. Influenza A virus PB1-F2 protein: An ambivalent innate immune modulator and virulence factor.
Cheung PH; Lee TT; Chan CP; Jin DY
J Leukoc Biol; 2020 May; 107(5):763-771. PubMed ID: 32323899
[TBL] [Abstract][Full Text] [Related]
2. Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease.
McAuley JL; Tate MD; MacKenzie-Kludas CJ; Pinar A; Zeng W; Stutz A; Latz E; Brown LE; Mansell A
PLoS Pathog; 2013; 9(5):e1003392. PubMed ID: 23737748
[TBL] [Abstract][Full Text] [Related]
3. Influenza A virus protein PB1-F2 exacerbates IFN-beta expression of human respiratory epithelial cells.
Le Goffic R; Bouguyon E; Chevalier C; Vidic J; Da Costa B; Leymarie O; Bourdieu C; Decamps L; Dhorne-Pollet S; Delmas B
J Immunol; 2010 Oct; 185(8):4812-23. PubMed ID: 20844191
[TBL] [Abstract][Full Text] [Related]
4. PB1-F2 protein of highly pathogenic influenza A (H7N9) virus selectively suppresses RNA-induced NLRP3 inflammasome activation through inhibition of MAVS-NLRP3 interaction.
Cheung PH; Ye ZW; Lee TT; Chen H; Chan CP; Jin DY
J Leukoc Biol; 2020 Nov; 108(5):1655-1663. PubMed ID: 32386456
[TBL] [Abstract][Full Text] [Related]
5. Pro-inflammatory Effects of Influenza Type A Virus PB1-F2 Protein-derived Peptide in Lipopolysaccharide-treated Macrophages.
Kalantar K; Farzaneh Z; Gholijani N; Hosseini SY; Bani Hasan E
Iran J Allergy Asthma Immunol; 2020 May; 19(S1):74-82. PubMed ID: 32534514
[TBL] [Abstract][Full Text] [Related]
6. H5N1 Influenza A Virus PB1-F2 Relieves HAX-1-Mediated Restriction of Avian Virus Polymerase PA in Human Lung Cells.
Mazel-Sanchez B; Boal-Carvalho I; Silva F; Dijkman R; Schmolke M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29563290
[TBL] [Abstract][Full Text] [Related]
7. Identification of a short sequence motif in the influenza A virus pathogenicity factor PB1-F2 required for inhibition of human NLRP3.
Silva F; Boal-Carvalho I; Williams N; Chabert M; Niu C; Hedhili D; Choltus H; Liaudet N; Gaïa N; Karenovics W; Francois P; Schmolke M
J Virol; 2024 May; 98(5):e0041124. PubMed ID: 38567952
[TBL] [Abstract][Full Text] [Related]
8. Non-avian animal reservoirs present a source of influenza A PB1-F2 proteins with novel virulence-enhancing markers.
Alymova IV; York IA; McCullers JA
PLoS One; 2014; 9(11):e111603. PubMed ID: 25368997
[TBL] [Abstract][Full Text] [Related]
9. Strain-dependent effects of PB1-F2 of triple-reassortant H3N2 influenza viruses in swine.
Pena L; Vincent AL; Loving CL; Henningson JN; Lager KM; Li W; Perez DR
J Gen Virol; 2012 Oct; 93(Pt 10):2204-2214. PubMed ID: 22815274
[TBL] [Abstract][Full Text] [Related]
10. Evolution and Virulence of Influenza A Virus Protein PB1-F2.
Kamal RP; Alymova IV; York IA
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286299
[TBL] [Abstract][Full Text] [Related]
11. Virulent PB1-F2 residues: effects on fitness of H1N1 influenza A virus in mice and changes during evolution of human influenza A viruses.
Alymova IV; McCullers JA; Kamal RP; Vogel P; Green AM; Gansebom S; York IA
Sci Rep; 2018 May; 8(1):7474. PubMed ID: 29749408
[TBL] [Abstract][Full Text] [Related]
12. Influenza A virus protein PB1-F2 impairs innate immunity by inducing mitophagy.
Wang R; Zhu Y; Ren C; Yang S; Tian S; Chen H; Jin M; Zhou H
Autophagy; 2021 Feb; 17(2):496-511. PubMed ID: 32013669
[TBL] [Abstract][Full Text] [Related]
13. Emergence of Highly Pathogenic Avian Influenza A(H5N1) Virus PB1-F2 Variants and Their Virulence in BALB/c Mice.
Kamal RP; Kumar A; Davis CT; Tzeng WP; Nguyen T; Donis RO; Katz JM; York IA
J Virol; 2015 Jun; 89(11):5835-46. PubMed ID: 25787281
[TBL] [Abstract][Full Text] [Related]
14. PB1-F2 Protein Does Not Impact the Virulence of Triple-Reassortant H3N2 Swine Influenza Virus in Pigs but Alters Pathogenicity and Transmission in Turkeys.
Deventhiran J; Kumar SR; Raghunath S; Leroith T; Elankumaran S
J Virol; 2016 Jan; 90(1):222-31. PubMed ID: 26468540
[TBL] [Abstract][Full Text] [Related]
15. Influenza virus protein PB1-F2 interacts with CALCOCO2 (NDP52) to modulate innate immune response.
Leymarie O; Meyer L; Tafforeau L; Lotteau V; Costa BD; Delmas B; Chevalier C; Le Goffic R
J Gen Virol; 2017 Jun; 98(6):1196-1208. PubMed ID: 28613140
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to PB1-F2 protein are induced in response to influenza A virus infection.
Krejnusová I; Gocníková H; Bystrická M; Blaskovicová H; Poláková K; Yewdell J; Bennink J; Russ G
Arch Virol; 2009; 154(10):1599-604. PubMed ID: 19672555
[TBL] [Abstract][Full Text] [Related]
17. The influenza A virus protein PB1-F2: killing two birds with one stone?
Varga ZT; Palese P
Virulence; 2011; 2(6):542-6. PubMed ID: 21971186
[TBL] [Abstract][Full Text] [Related]
18. NLRX1 prevents mitochondrial induced apoptosis and enhances macrophage antiviral immunity by interacting with influenza virus PB1-F2 protein.
Jaworska J; Coulombe F; Downey J; Tzelepis F; Shalaby K; Tattoli I; Berube J; Rousseau S; Martin JG; Girardin SE; McCullers JA; Divangahi M
Proc Natl Acad Sci U S A; 2014 May; 111(20):E2110-9. PubMed ID: 24799673
[TBL] [Abstract][Full Text] [Related]
19. Rapid evolution of the PB1-F2 virulence protein expressed by human seasonal H3N2 influenza viruses reduces inflammatory responses to infection.
McAuley J; Deng YM; Gilbertson B; Mackenzie-Kludas C; Barr I; Brown L
Virol J; 2017 Aug; 14(1):162. PubMed ID: 28830486
[TBL] [Abstract][Full Text] [Related]
20. The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein.
Varga ZT; Ramos I; Hai R; Schmolke M; García-Sastre A; Fernandez-Sesma A; Palese P
PLoS Pathog; 2011 Jun; 7(6):e1002067. PubMed ID: 21695240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
